COVID-19 Cases Rise as Omicron-Derived FLiRT, LB.1 Variants Take Hold
Drug Topics
JULY 15, 2024
Updated vaccines are expected to be available in the coming months.
Mon.Jul 15, 2024
530 
Is a better CAR-T cell therapy option on the horizon?
PharmaVoice
JULY 15, 2024
In vivo CAR-T cell technology has the potential to solve some major issues in the field and could enter the clinic this year.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Overcoming PTSD: Farron Dozier Discusses His Experience in the US Army
Drug Topics
JULY 15, 2024
Farron Dozier, former sergeant first class in the US Army, sat down with Drug Topics on a recent episode of Over the Counter to discuss his experience with PTSD.
Mining clues from a library of brain tissue samples, Cerevance takes a precision approach to CNS disorders
PharmaVoice
JULY 15, 2024
Mid-stage data from the company’s lead candidate in Parkinson’s is expected later this year and could tee up an IPO.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Medication, Health Care Affordability Improved During COVID-19 Pandemic
Drug Topics
JULY 15, 2024
Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.
Opinion: Functional neurological disorder is not an appropriate diagnosis for people with long Covid
STAT
JULY 15, 2024
Long Covid — the name adopted for cases of prolonged symptoms after an acute bout of Covid-19 — is an umbrella diagnosis covering a broad range of clinical presentations and abnormal biological processes. Researchers haven’t yet identified a single or defining cause for some of the most debilitating symptoms associated with long Covid, which parallel those routinely seen in other post-acute infection syndromes.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Bird flu snapshot: As the number of infected dairy herds mount, so too does pessimism about driving H5N1 out of cows
STAT
JULY 15, 2024
Bird flu snapshot: This is the latest installment in a series of regular updates on the H5N1 flu outbreak in dairy cows that STAT is publishing on Monday mornings. To read future updates, you can also subscribe to STAT’s Morning Rounds newsletter. There are more human cases of H5N1 bird flu infection, and another state has joined the list of those with infected dairy cow herds.
G900 Region In Th2 Differentiation May Have Significant Implications in Asthma, Other Conditions
Pharmacy Times
JULY 15, 2024
The findings demonstrate that the mG900 region plays a significant role in Type-2 helper T (Th2) cell differentiation and enhances allergic airway inflammation.
STAT+: Top FDA officials weighing regulation of ultra-processed foods, internal documents show
STAT
JULY 15, 2024
WASHINGTON – Top Food and Drug Administration officials met multiple times earlier this year to discuss the regulation of ultra-processed foods, according to internal agency calendars obtained by STAT. Two FDA officials, Haider Warraich and Robin McKinnon, met multiple times in February to discuss regulating these edible industrial creations, such as sodas, prepackaged cookies, and most breakfast cereals.
Atropos compares how well leading LLMs generate clinical evidence
Fierce Healthcare
JULY 15, 2024
A new study released by healthcare AI company Atropos found that general purpose LLMs like ChatGPT, Claude and Gemini are not fit for use in clinical decisionmaking. | Healthcare AI company Atropos conducted a study to test how reliably ChatGPT, Claude, Gemini, OpenEvidence and its own model, ChatRWD, answer clinicians' questions. General use LLMs did not fare well.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Vertex sues U.S. government over access to fertility support services for Casgevy patients
STAT
JULY 15, 2024
One of the makers of Casgevy — the world’s first CRISPR-based medicine — filed a lawsuit Monday intended to clear the way for the company to pay for fertility preservation services and treatment for people receiving the therapy, which can interfere with reproduction. In the lawsuit, Vertex Pharmaceuticals challenged an oral opinion issued by the Health and Human Services Office of the Inspector General that its fertility support program would violate federal anti
FDA proposes cell and gene therapy site tours to help regulators learn from industry
Fierce Pharma
JULY 15, 2024
It's no secret that cell and gene therapies have faced manufacturing hurdles as the advanced medicines have become increasingly popular in recent years. | It's no secret that cell and gene therapies have faced manufacturing hurdles as the advanced medicines have become increasingly popular in recent years. Now, the FDA is proposing to work directly with industry through a series of facility tours that could enable both sides to learn something from each other.
STAT+: The effort to reform physician pay is set to pit primary care docs against highly paid specialists
STAT
JULY 15, 2024
WASHINGTON — There’s been a long lull in fighting between primary care and specialty doctors over how much they get paid by Medicare, but that truce might not last if Congress overhauls the system that determines physician payment. This year, Congress began considering changes to the Medicare physician pay system for the first time since creating the current version in 2015.
Amgen, BMS and Merck have the most exposure as Big Pharma eyes $183B patent cliff: analyst
Fierce Pharma
JULY 15, 2024
While patent cliffs are looming for many of biopharma’s top-selling products, the industry has enormous capacity to respond as “conditions for M&A are favorable,” according to a research note f | While patent cliffs loom for many of biopharma’s top-selling products, the industry has enormous capacity to respond as “conditions for M&A are favorable,” according to a July 11 research note from Morgan Stanley.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Q&A: Why more info can lead some women to prefer delaying first mammogram
STAT
JULY 15, 2024
The messaging around mammography often doesn’t go beyond this simple three-word refrain: screening saves lives. Medical groups have also moved toward earlier breast cancer screening: The United States Preventive Services Task Force, for example, earlier this year recommended that all women begin screening mammography at age 40. And yet, more women prefer to wait until age 50 to begin screening after learning about breast cancer screening’s benefits and drawbacks, according to a stu
Chicago safety-net hospital's former CFO charged in $15M embezzlement scheme
Fierce Healthcare
JULY 15, 2024
A Chicago safety-net hospital’s former chief financial officer and chief transformation officer have been charged for their alleged roles in a scheme to embezzle over $15 million from the nonprofit | Loretto Hospital's chief financial officer as well as its chief transformation officer allegedly authorized payments for bogus vendor goods and services.
Opinion: Medicare drug pricing rules will delay access to promising therapies
STAT
JULY 15, 2024
Medicare’s new guidelines cover how it will conduct the drug price negotiations authorized by the Inflation Reduction Act. Unfortunately, the Centers for Medicare and Medicaid Services is interpreting the law in a way that will discourage companies from finding new uses — sometimes lifesaving new uses — for existing drugs. It will also deter companies from doing research on existing medicines to create improved versions that are more effective and have fewer side effects.
FTC probing DaVita, Fresenius Medical Care's noncompetes for dialysis clinic medical directors
Fierce Healthcare
JULY 15, 2024
The Federal Trade Commission (FTC) has opened a probe into the country’s two largest dialysis care providers and the terms of their contracts with physicians, according to a weekend report that has | A DaVita representative described a weekend report of the probe as "old news" and "not something that we feel like there’s an enormous amount of stress over.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Early data from Lexeo’s gene therapy for rare heart disease shows promise
STAT
JULY 15, 2024
Lexeo Therapeutics said Monday that a gene therapy designed to prevent fatal cardiac complications of a genetic disorder called Friedrich’s ataxia reduced signs of heart disease in a handful of patients. The data are very early and less-than-clear-cut. But given a top Food and Drug Administration official’s recent efforts to advance gene therapies under accelerated approval — most notably, with the decision to expand approval for Sarepta’s Duchenne muscular dystrophy
Germany inches closer to confidential pricing for drugs
pharmaphorum
JULY 15, 2024
Germany inches closer to confidential pricing for patented medicines, with passage of Medical Research Act
What are the odds we get an heir to Paxlovid?
STAT
JULY 15, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we look at some promising, but early, gene therapy data from Lexeo Therapeutics, examine Medicare’s new price negotiation rules and their impact on innovation, and more.
No Surprises Act audit finds inaccurate calculations by Aetna of Texas
Fierce Healthcare
JULY 15, 2024
The Centers for Medicare & Medicaid Services (CMS) released an audit showing Aetna Health of Texas miscalculated a key metric and was not following federal guidelines as set out by the No Surpr | The first No Surprises Act audit of health plans found significant errors in how Aetna Health of Texas calculated the qualifying payment amount for air ambulance services.
STAT+: Medicare pay proposals are good news for health tech, bad news for docs
STAT
JULY 15, 2024
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox every Monday. Just you, a beach chair, and Medicare regs Medicare dropped its own summer reading list last week — a tidy 3,200 pages of regulations that govern how doctors , surgery centers, and hospital outpatient departments will get paid next year.
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer
Fierce Pharma
JULY 15, 2024
CAR-T specialist Legend Biotech has reportedly received a takeover bid and has tapped Centerview Partners as a financial adviser to evaluate its options, StreetInsider
Call goes out for simpler clinical trial regulation in UK
pharmaphorum
JULY 15, 2024
Framework governing early-stage clinical trials in the UK is stifling research and needs to be simplified, says BJCP paper
Biosimilar Disease-Modifying Antirheumatic Drugs Show Potential Cost Savings for Rheumatoid Arthritis
Pharmacy Times
JULY 15, 2024
After failure with methotrexate, treatment with leflunomide is typically recommended, but treatment with biosimilars could have greater quality-adjusted life years.
Pharma Pulse 7/15/24: What to Know About Medication and Summer Travel, The Future of Periodontal Treatment & more
Pharmaceutical Commerce
JULY 15, 2024
The latest news for pharma industry insiders.
Investors take issue with Taisho Pharma’s buyout price
pharmaphorum
JULY 15, 2024
Two investment funds have decided to contest Taisho Pharma’s recently announced management buyout plan in court
Expert: Stigma, Price Point Major Obstacles for Widespread OTC Naloxone Use
Pharmacy Times
JULY 15, 2024
Allison Burns, president and CEO of EMO Health, discusses the price point and stigma surrounding OTC naloxone in an interview with Pharmacy Times.
GSK moves back to its roots with new central London headquarters
Fierce Pharma
JULY 15, 2024
After two decades headquartered in the West London suburb of Brentford, GSK is officially coming home to central London. | After two decades headquartered in the West London suburb of Brentford, GSK's new digs are officially open and will house 3,000 workers in London's Knowledge Quarter.
Consumer-Wearable Devices for Patients With Heart Failure, Atrial Fibrillation Have Clinical Implications
Pharmacy Times
JULY 15, 2024
Consumer-wearable devices can monitor treatment response and provide continuous health data for patients with heart disease and atrial fibrillation.
How to increase blood oxygen levels
The Checkup by Singlecare
JULY 15, 2024
Oxygen is essential to life—just three to six minutes without oxygen can cause brain damage or even death. Your blood oxygen level, or the amount of oxygen circulating in the blood, can be an indicator of your overall wellness. You can even measure your blood oxygen level at home with a device called a pulse oximeter. The device is placed on a finger (a toe or earlobe may also be used) and uses a light to measure your oxygen saturation.
Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation
Pharmaceutical Commerce
JULY 15, 2024
A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.
Let's personalize your content